NASDAQ:MDRX
Allscripts Healthcare Solutions Stock News
$7.60
+0.0500 (+0.662%)
At Close: Apr 19, 2024
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
12:02pm, Wednesday, 07'th Dec 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Allscripts Healthcare Solutions: The Picture Is Improving
12:17pm, Tuesday, 22'nd Nov 2022
Allscripts Healthcare Solutions has done well to post sales and cash flow growth in recent quarters. The company still faces uncertainty and risks moving forward, but it's healthy and trading on the c
Allscripts Healthcare Solutions, Inc. (MDRX) Q3 2022 Earnings Call Transcript
04:59pm, Saturday, 05'th Nov 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Richard Poulton - CEO Thomas Langan - Pres
Allscripts (MDRX) Q3 Earnings Surpass Estimates, Margins Up
11:18am, Friday, 04'th Nov 2022
Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.
AllScripts Healthcare (MDRX) Q3 Earnings Top Estimates
06:48pm, Thursday, 03'rd Nov 2022
AllScripts (MDRX) delivered earnings and revenue surprises of 21.05% and 0.68%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
01:32pm, Monday, 10'th Oct 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
MDRX vs. OMCL: Which Stock Is the Better Value Option?
12:47pm, Wednesday, 05'th Oct 2022
MDRX vs. OMCL: Which Stock Is the Better Value Option?
MDRX vs. OMCL: Which Stock Should Value Investors Buy Now?
12:47pm, Tuesday, 09'th Aug 2022
MDRX vs. OMCL: Which Stock Is the Better Value Option?
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Rick Poulton on Q2 2022 Results - Earnings Call Transcript
08:02pm, Sunday, 07'th Aug 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Jenny Gelinas - VP, IR Rick Poulton - CEO Tom Langan - President an
AllScripts Healthcare (MDRX) Tops Q2 Earnings and Revenue Estimates
07:33pm, Thursday, 04'th Aug 2022
AllScripts (MDRX) delivered earnings and revenue surprises of 12.50% and 2.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
01:50pm, Monday, 27'th Jun 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
03:12pm, Tuesday, 10'th May 2022 Zacks Investment Research
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
12:48pm, Tuesday, 10'th May 2022
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2021 Results - Earnings Call Transcript
09:22am, Sunday, 08'th May 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Jenny Gelinas - Vice President, Investor Relations Paul Black - Chief
Analyst Ratings for Allscripts Healthcare
08:32pm, Friday, 06'th May 2022 Benzinga
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
2
0
0
